Form 8-K - Current report:
SEC Accession No. 0000950170-25-038742
Filing Date
2025-03-13
Accepted
2025-03-13 16:11:41
Documents
12
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20250313.htm   iXBRL 8-K 44971
2 EX-99.1 lyra-ex99_1.htm EX-99.1 219466
  Complete submission text file 0000950170-25-038742.txt   394018

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20250313.xsd EX-101.SCH 24869
14 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20250313_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 25735875
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)